Cipher Pharmaceuticals Inc
CPH
Company Profile
Business description
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.
Contact
5750 Explorer Drive
Suite 404
MississaugaONL4W 0A9
CANT: +1 905 602-5840
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
6
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,805.00 | 21.40 | -0.24% |
CAC 40 | 7,723.47 | 27.20 | 0.35% |
DAX 40 | 24,073.67 | 286.22 | 1.20% |
Dow JONES (US) | 44,406.36 | 422.17 | -0.94% |
FTSE 100 | 8,806.53 | 16.38 | -0.19% |
HKSE | 24,076.63 | 188.80 | 0.79% |
NASDAQ | 20,412.52 | 188.59 | -0.92% |
Nikkei 225 | 39,704.10 | 116.42 | 0.29% |
NZX 50 Index | 12,859.02 | 94.07 | 0.74% |
S&P 500 | 6,229.98 | 49.37 | -0.79% |
S&P/ASX 200 | 8,566.30 | 23.00 | -0.27% |
SSE Composite Index | 3,496.50 | 23.38 | 0.67% |